Name: UMIN ID:
Unique ID issued by UMIN | UMIN000022535 |
---|---|
Receipt number | R000025919 |
Scientific Title | A phase II study for the safety and efficacy of TAS-102 and Bevacizumab for patients with unresectable colorectal cancer considering Oxaliplatin to stop and go. |
Date of disclosure of the study information | 2016/05/31 |
Last modified on | 2018/01/25 23:15:49 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/05/30 17:54:14 | ||
2 | Update | 2016/06/20 08:29:27 | Acronym Acronym |
|
3 | Update | 2017/05/31 10:39:04 | Recruitment status |
|
4 | Update | 2017/05/31 10:40:00 | Email1 |
|
5 | Update | 2018/01/25 23:15:49 | Recruitment status Date analysis concluded |